Bentolero, Jay-ann T.
HRN: 10-65-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2024
CEFUROXIME 500MG (TAB)
02/21/2024
02/28/2024
PO
500mg
BID
S/P NSVD With RMLE And Repair; PROM X 11 Hrs
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes